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Abstract 
Total body hypothermia is an established neuroprotectant in global ischemia.  Applying 
hypothermia selectively could provide more rapid cooling and eliminate systemic side 
effects.  We studied the effect of selective hypothermia in a novel stroke model in adult 
domestic swine.   
Via craniotomy under general anesthesia, one middle cerebral artery branch was occluded for 
3 hours followed by 3 hours of reperfusion.  In half the animals, hypothermia was induced 
during reperfusion via a dual-lumen balloon occlusion catheter placed in the carotid 
ipsilateral to the ischemic region.  Following reperfusion, the animals were sacrificed.  Brain 
MRI and histology were evaluated blinded to the intervention. 
In this series of 28 animals, the mean temperature achieved was 26.5C.  Mean time from start 
of perfusion to attainment of moderate hypothermia (< 30 C) was 25.4 minutes.  Mean 
histologic stroke volume was reduced by 38.4-44.2% (p=0.292).   Percentage stroke seen on 
MRI showed a significant reduction(p=0.042) 
Selective moderate hypothermia was rapidly induced using endovascular technology. A 
promising reduction in stroke volumes is seen.  Further study is warranted.  
Keywords 
Selective hypothermia, Focal cerebral ischemia, Stroke, Endovascular, Porcine 
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Chapter 1  
1 Background 
1.1 Introduction. 
As a form of neuroprotection, hypothermia is the only one that has stood the test of time. 
Numerous animal studies and in recent years even some human ones point to its 
protective effect. In the application of hypothermia during surgical procedures, early 
investigators recognized both its potential power but also the systemic risks associated 
with its use.   
A surge of interest has recently arisen in the application of hypothermia to ischemic 
stroke. This stems from developments in endovascular catheter technology, which can 
provide hypothermia more rapidly than traditional surface cooling techniques 
(DeGeorgia, Froehler), and also provide it to more selective regions of the body including 
the brain. Our purpose was to evaluate catheter technology as a means of selectively 
cooling an ischemic region of brain. Focal cooling potentially avoids the systemic 
complications of hypothermia, while providing moderate hypothermia rapidly and 
efficiently. 
 
1.2 The history of total-body and selective 
hypothermia 
 Interest in hypothermia as a protection against hypoxic-ischemic injury during 
surgery dates back to the 1950s (Bigelow, Botterell, Lougheed). At that time, efforts to 
improve surgery on both the heart and the brain led to investigations as to how to 
improve tolerance to circulatory arrest and resultant hypoxia.  For cardiac surgeons the 
issue was with direct surgery on the heart, which would require cardiac standstill, and 
which without some form of protection would result in cerebral ischemia (Bigelow).  For 
neurosurgeons the tantalizing possibility lay in being able to operate in a bloodless field 
in the depths of the cranium to precisely reconstruct diseased blood vessels. This led to 
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interest in methods to arrest cerebral blood flow while improving the brain’s tolerance to 
ischemia (Botterell, Lougheed). 
These lines of investigation were focused on two different forms of cerebral ischemia.  
The cardiac surgeons were interested in the prevention of global ischemia due to cardiac 
standstill. For the neurosurgeons the interest was in preventing focal ischemia due to 
temporary occlusion of a single brain artery (Lougheed, Drake, Lawton).  Temporary 
occlusion provides the advantage of  softening of the brain aneurysm sac, allowing 
manipulation and obliteration with a reduced risk of aneurysm rupture. But temporary 
occlusion comes at the cost of potential stroke in the territory supplied by the artery. 
Providing hypothermia could decrease the metabolic demand of neural tissue and 
decrease the risk of stroke. 
The metabolic effect of hypothermia was established in canine experiments the 1950s by 
Lougheed, who found a 50% reduction in cerebral metabolic rate at 28°C, and a 75% 
reduction at 25°C (Lougheed). Given the degree to which cerebral metabolism was 
reduced by moderate hypothermia, it seemed logical that it would be protective during 
induced ischemia.  Initially cooling was performed by whole body ice water bath, but 
cardiac dysrrhythmias limited the degree of cooling to 30°C (Botterell).  Later studies 
utilized full cardiac bypass with profound hypothermia(10-15°C), but untoward bleeding 
was a significant problem (Drake, Lawton). 
The recognition of these systemic side-effects led to interest in focal or selective 
hypothermia applied to the area at risk for ischemia. Lougheed et al first proposed local 
or selective hypothermia in 1955 as a way of circumventing the cardiac arrhythmia 
problem (Lougheed).  Using a bypass pump attached to a carotid artery in dogs, he was 
able to reduce brain temperature to 20°C in 20 minutes, while the systemic body 
temperature only dropped to 35°C.  The approach was abandoned when all the dogs 
developed fatal arrhythmias.  However, additional canine experiments by Verdura were 
able to overcome this issue with impressive clinical results (Verdura). Of 16 animals 
treated with femoral-carotid bypass hypothermia and concurrent ischemia, all survived 
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and only 2 had permanent deficits, whereas none of the 5 normothermic controls 
survived. 
Subsequently, a human trial of selective catheter-based brain cooling during surgery for 
aneurysms and tumours was undertaken in the 1960s (Willams).  Although 10 patients 
achieved deep hypothermia of less than 20°C, bleeding complications led to a 50 per cent 
mortality rate. It was concluded that selective brain cooling was inferior to open chest 
cardiopulmonary bypass techniques. However the excessive mortality may have been due 
in part to the technique. The surgical procedure involved the isolation of all 4 arteries to 
the brain in order to perfuse the brain through one of them, the other three being 
clamped.Supra-normal infusion pressures were then used to achieve total brain cooling in 
Williams’ study.  
Despite these early challenges, the scientific allure of hypothermia for brain ischemia 
continues, due to repeated demonstrations of reduced stroke volume in animal studies. 
Animal studies have included both global and focal ischemic models, in both small and 
large animals, and using different timing of induction of hypothermia in relation to the 
onset of ischemia. In one study, a global ischemic model in swine with a full 20 minute 
period of cardiac arrest, femoral–to–carotid bypass using cooled blood for 12 hours led to 
brain temperatures of 32-34°C with drops in body temperature to only 35°C (Mori, Mori 
2).  Histological grading in the CA1 region of the hippocampus, an area known for 
ischemia-sensitive neurons, demonstrated significantly better scores in animals that 
received hypothermia.  In a canine model of global ischemia, clamping off 3 vessels and 
perfusing the brain solely through the right vertebral artery with cold Ringer’s lactate led 
to marked drops in brain temperature with no evidence of cerebral ischemic damage 
either clinically or histologically (Ohta). 
The above were studies of global ischemia during cardiac arrest.  However with 
neuroscientists’ interest in focal ischemia, many studies have used focal ischemic models 
instead.  One common model utilizes rodents in which one middle cerebral artery and the 
ipsilateral or both carotids are occluded.  In many such studies, infarct volumes have been 
found to be smaller compared with normothermic controls  (Huang, Kozlowski, Xue, 
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Onesti, Goto ).  These studies differ in the degree of hypothermia and in the timing of 
hypothermia in relation to the ischemic insult.  Hypothermia was generally induced by 
whole body cooling, and the method, although considered focal, involves a more 
significant loss of blood flow to the whole brain than a focal model would in a larger 
animal.  Also, rats probably tolerate a greater degree of hypothermia without cardiac 
arrhythmias than higher order mammals such as humans.  In one study, whole body 
cooling to less than 24°C was tolerated (Onesti).  
The timing of the induction of hypothermia relative to the ischemic insult is an interesting 
area of study (Onesti).  While ischemic insults applied during hypothermia have shown 
promise, the reverse also appears to be true (Goto, Xue, Huang).  In other words, 
hypothermia can be induced hours after the ischemic insult or even during reperfusion, 
and stroke volumes will still be reduced compared with normothermic controls.  
Proposed mechanisms for this benefit include the protection of “penumbra” neurons at 
the peripheral zone of ischemia, suppression of excitatory neurotransmitters, and 
suppression of leukotrienes (Onesti). During reperfusion with hypothermia there are 
measurable reductions in ischemic metabolites such as lactate and high energy 
phosphates (Koslowski). Hypothermia during reperfusion also leads to reduction in one 
form of blood-brain-barrier disruption (Huang). Thus based on rodent studies it would 
appear that hyperacute stroke may benefit from hypothermia applied during reperfusion. 
 Although rodents are easily handled, tolerate moderate to deep hypothermia with whole 
body cooling, and have provided insight into the mechanisms behind hypothermia’s 
benefit, the transferability of these findings to higher order mammals is not clear.  
Humans do not tolerate temperatures much below 32°C without significant cardiac effect 
(Botterell). Furthermore, whole body cooling can take hours to induce, and thus its 
applicability to acute stroke is limited, where even an hour’s delay can be critical 
(Froehler). 
In swine, focal ischemic models have become more established in recent years.  Sakoh 
and colleagues used full size pigs to compare cerebral metabolic rate of oxygen (CMRO2) 
using positron emission (PET) scanning with activated diffusion coefficient (ADC) 
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changes using magnetic resonance (MR) imaging. Their model was proximal occlusion 
of the middle cerebral artery (MCA) (Sakoh).  Smaller models using either infant or 
miniature piglets have also been described, which allow study of permanent or temporary 
MCA occlusion (Imai, Kuluz, Cooper).  Unlike rodents, no additional carotid clamping is 
required, making swine models much more like the human acute stroke situation. 
While small porcine models are considered advantageous for ease of handling and for 
craniotomy (Imai), their vasculature is too small to evaluate the use of endovascular tools 
designed for humans.  Larger pigs have been used for endovascular equipment evaluation 
and training for close to three decades (Massoud, Guglielmi, Lee). Thus a stroke model in 
domestic swine would be ideal to study endovascular approaches to selective brain 
cooling. 
 
 
 
1.3 The Argument for Selective Hypothermia 
The failure of selective brain cooling observed in humans during the 1960s has been 
noted above. However based on animal studies and on the avoidance of cardiac and 
bleeding complications, further investigations into this promising technique continue. In 
one study in baboons, a femoral-to-carotid circuit was used to cool the ipsilateral cerebral 
hemisphere to under 25°C via one carotid artery. This was rapidly performed within a 
mean of 12 minutes, and maintained for 3h with only minimal systemic cooling to 34°C 
(Schwartz).  No hemodynamic complications were noted, although 2 of 12 animals died 
due to other complications. A second study involved swine, first as a feasibility study, in 
which brain temperatures were reduced to 30°C in 30 min without reducing core 
temperature below 34°C (Mori).  Subsequently, the same group induced a global 
ischemic insult in the form of controlled cardiac arrest for 20 minutes, then randomly 
provided selective cooling for 12 hours. There was a statistically significant improvement 
in histological scores in the cooled group compared with controls (Mori 2).  Brain 
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temperatures in this study were more in the moderate range (32-34°C) while core 
temperatures dropped to 35°C.  Most recently, a small study in baboons demonstrated 
significant reductions in stroke volume by MRI in selective hypothermia maintained over 
12hours (Schwartz 2). 
 
Recently, ice-cold saline has been proposed as a method for selective cooling.  A 
theoretical study predicted that brain temp less than 35°C would be achieved in 10 
minutes at infusion rates of 20ml/min (Konstas).  A clinical pilot study in humans 
demonstrated internal carotid artery infusions of ice-cold saline at 33 ml/min for 10 
minutes led to a statistically significant drop in jugular venous bulb temperatures 
compared with core temperatures (Choi).  The magnitude of the drop was small (0.84°C 
versus 0.15°C).  However, the authors suggested that this form of selective brain cooling 
might be useful in acute stroke as a bridge to recanalization and to prevent reperfusion 
complications.   
Finally, Lownie et al utilized a femoral-carotid bypass to induce selective hypothermia 
during the evacuation and clipping of a giant middle cerebral artery aneurysm (Lownie).  
Both safety and utility were demonstrated in this case report, with temporary occlusion 
times of approximately 20 minutes, and a brain temperature of 22°C, without evidence of 
stroke, hemodynamic or cardiac changes, or coagulopathy.    
1.4 Potential Utility of Selective Hypothermia in Acute 
Ischemic Stroke 
Given the demonstrable effect of hypothermia in reducing stroke volumes in both small 
and large animal models, as well as significant human data suggesting benefit of 
hypothermia in preventing ischemic injury, the utility of hypothermia for treatment after 
a focal ischemic insult is an area of active research.  In a rodent model, delaying 
hypothermia until 1.5 hours after the ischemic insult still showed decreased infarct 
volumes, although not as dramatically as with concurrent hypothermia (Xue).  In clinical 
trials, hypothermia is beneficial after cardiac arrest (Holzer).  There is some disagreement 
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about the length of time required for benefit but depth of hypothermia may not be as 
important (Yenari). In acute ischemic stroke, multiple authors suggest that hypothermia 
may be useful as a bridge to recanalization (Choi, Yenari, Schwartz, Froehler).   
One barrier to clinical utility is the rapidity of hypothermia induction.  This is not an 
issue for rodent studies, but whole body cooling in humans takes a significant amount of 
time. The rate of cooling may be an important determinant for clinical utility in stroke 
(Froehler).  The COOLAID study demonstrated that endovascular cooling combined with 
a drug cocktail (to prevent shivering) achieved target temperature in just over an hour, 
compared with surface cooling technology which can take over 4 hours (De Georgia).  
However, stroke volume was not reduced.   
A subsequent human clinical trial called ICTuS-L evaluated the combination of FDA-
approved intravenous tPA and endovascular hypothermia for the treatment of acute 
ischemic stroke (Hemmen).  This was the first trial to evaluate a demonstrated stroke 
therapy with hypothermia, but unfortunately could not enroll enough patients to evaluate 
whether hypothermia might extend the treatment window for intravenous therapy.  Like 
COOLAID, there were no significant differences in clinical outcome or mortality, 
although pneumonia was more commonly seen in the hypothermia treatment arm.   
Despite the negative results in COOLAID and ICTUS-L, endovascular methods would 
seem to be ideal for the application of hypothermia to acute ischemic stroke.  
Endovascular cooling is significantly more rapid than whole body or surface cooling 
methods.  By being selective, endovascular cooling should reduce or avoid the systemic 
side effects of cardiac dysfunction and coagulopathy, while providing a greater depth of 
hypothermia.   Finally, endovascular techniques are already in use as recanalization 
strategies for stroke, so adding catheter-delivered hypothermia to the mix makes sense as 
a “neuroprotective bridge” to recanalization (Choi, Yenari, Schwartz, Froehler). 
A new catheter technology to administer selective cooling has become available.  This is 
the “Duo-Flo” dual lumen catheter (Thermopeutix Inc., San Diego, CA). The catheter 
consists of a 9.5 French balloon catheter coaxially introduced through a 14 French outer 
catheter.  The outer catheter is positioned in the aorta, and is used to withdraw blood to 
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an extracorporeal perfusion unit, wherein the blood is cooled and then reinfused via the 
balloon catheter into the common carotid artery ipsilateral to the ischemic zone.  The 
Duo-Flo has received 510k approval for human use in 2010 from the U.S. Food and Drug 
Administration (personal communication, Thermopeutix Inc.). 
The ideal animal model provides both a reproducible ischemic stroke and a relative size 
similar to humans for endovascular catheter work.  Endovascular training models in pigs 
weighing 30-45kg are well established (Guglielmi, Massoud, Lee).  The senior author has 
extensive experience with such models for endovascular device evaluation.  Also, stroke 
models in pigs are well established (Sakoh, Imai, Cooper).  Pigs have a relatively thick 
skull that has led investigators to use either transorbital approaches (Sakoh), or smaller 
specimens (Imai, Cooper). However,  miniature or immature pigs would not allow the use 
of human-size endovascular instruments.  
A large animal model of acute focal ischemia with which to test theory and application of 
selective hypothermia is therefore required. 
There remains a significant mismatch between the potential promise of hypothermia for 
acute stroke and actual human data.  Despite decades of successful animal 
experimentation using hypothermia in both global and focal ischemia models, and recent 
clinical trials showing benefit in both adults and neonatal global ischemia, there is no 
evidence that supports the use of hypothermia for stroke in humans (Heleen, Yenari, 
Froehler).  This could be due to the prolonged time to induce whole body hypothermia, 
uncertainties regarding the depth and duration of hypothermia required for clinical 
benefit, and limitations to whole body hypothermia imposed by systemic complications.  
While some of these factors could be addressed using selective hypothermia, the benefit 
of hypothermia in human stroke remains hypothetical.  A large animal model could 
address these issues in a transferable way prior to further human trials.  
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Chapter 2 
2 Integrated Manuscript 
2.1 Introduction  
The extensive history of hypothermia, including successes in both animal series and 
human clinical trials, suggests that it may be effective in acute ischemic stroke.  The 
hurdles include the speed of application, as well as uncertainties regarding the depth and 
duration of hypothermia (Froehler).  The COOLAID and ICTUS-L trials, as well as 
animal selective hypothermia series, suggest that combining selective hypothermia with 
an endovascular approach could allow rapid induction of therapeutic hypothermia within 
a time frame meaningful in acute stroke (DeGeorgia, Ohta, Mori, Schwartz) 
We wished to test two hypotheses.  First, that moderate hypothermia can be induced 
rapidly in a swine model of focal ischemia through percutaneous catheter technology.  
Second, that ischemic stroke volumes in the swine model can be reduced through 
catheter-delivered hypothermia.   We utilized an adult porcine model of temporary 
occlusion of the middle cerebral artery, followed by the percutaneous introduction of an 
endovascular dual-lumen cooling catheter (Duo-Flo, Thermopeutix Inc. San Diego, CA) 
to provide an aorta-to-carotid bypass circuit for selective hypothermia ipsilateral to the 
ischemic territory.  We evaluated both the utility and efficacy of this method in a series of 
animals, alternating normothermic controls with others undergoing intervention with 
hypothermia during the reperfusion phase. 
2.2 Methods 
2.2.1 Set up and craniotomy 
Animals were used under an approved protocol of the Schulich School of Medicine and 
Dentistry AUP 2009-079 at Western University.  50 kg adult swine were anesthetized 
using 1-2 mL subcutaneous Telazol (Fort Dodge, IA), then intubated and maintained with 
a nitrous oxide-isofluorane mixture.  Arterial and central venous monitoring is obtained 
via bilateral transfemoral 6F sheath placement.  A frontal-orbital craniotomy is performed 
 (Fig 1).  This requires a perforator and 
and Leksell rongeurs to thin the intervening cranium.  Kerrison punches are used to 
connect the burr holes and widen the craniotomy.  Once the frontal and temporal dura is 
exposed, the microscope is used for orbital roof resection. 
Figure 1Craniotomy. A.  Right skin incision extending from the medial orbit 
superiorly then posteriorly over the calvarium, 
anterior to the ear.  B. Superficial exposure, with temporalis muscle reflected 
inferiorly, and the periorbita depressed.  C.  Two burr
periorbita depressed.  An
frontal and temporal dura, with retractor depressing the completely unroofed 
periorbita.  Arrowheads=temporalis muscle, Black arrow = periorbita, Open 
arrow=dura 
Hudson brace or other hand drill for 2 burr
 
 coursing inferiorly to the zygoma, 
 holes in the skull, with 
 emissary vein is typically found here.  D.   Full exposure of 
10 
 holes, 
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Once the orbital roof has been removed, the dura is opened in a cruciate fashion (Fig 2).  
The arachnoid is opened to release CSF, and the head of the bed elevated to allow 
maximal brain relaxation without the use of mannitol.  Under high magnification, the 
middle cerebral arteries (MCA) were located along the posterior frontal lobe.  Unlike 
humans, there are 2 or 3 MCA branches arising from the internal carotid artery as it 
continues anteriorly to become the anterior cerebral artery (Imai).  A temporary mini-clip 
is applied to a single branch.  This occlusion is continued for 3 hours. At the conclusion 
of 3 hours of temporary clipping, the microscope is brought back into the field, and the 
temporary clip is removed from the MCA branch.  The surgical field is then irrigated, and 
any remaining cottonoids are removed, but Gelfoam is allowed to remain.  The skin 
incision is closed with interrupted nylon suture. 
12 
 
 
Figure 2 Intradural Exposure  A.  Microscope view, cruciate dural incision.  B and 
C.  Exposure of the MCAs (usually 2-3 are seen).  D.  Final temporary clip 
placement across a single MCA. 
 
At this point, there is a 3-hour period of reperfusion.  If the animal is a normothermic 
control, it remains in the lateral decubitus until the last 30 minutes of a 3-hour reperfusion 
period.  If the animal is a hypothermic intervention, it is turned supine immediately on 
skin closure.  
2.2.2 Selective cooling technology 
Thermopeutix Inc. (San Diego, CA) provided the catheters used in the study.  Prior to the 
conclusion of temporary clipping, the Thermopeutix catheter is prepared on the 
backtable.  This catheter consists of a 14F Outer Flow Lumen (OFL) which is placed in 
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the descending aorta, and a 9.5F Inner Flow Lumen (IFL) balloon catheter placed in the 
ipsilateral common carotid artery (Fig 3).  There are two ports on the OFL and a check 
valve (Fig 4).  One port is attached to the outflow portion of an extracorporeal circuit, 
while the other is for continuous heparinized drip and flushing.  The IFL has 3 ports, 
flushed as usual, and a rotating hemostatic valve which is attached to a heparinized drip.  
One port is attached to the extracorporeal circuit for infusion of cooled blood.  The 
second port is the balloon inflation lumen, which is prepped with 50:50 contrast and 
saline.  The third port is a pressure transducer distal to the balloon for infusion pressure 
measurement.  All ports are attached to 3 way stopcocks. 
 
Figure 3 Thermopeutix catheter.  Distal end of the inner and outer Duo-Flo 
catheters showing the aortic outflow catheter with the carotid inflow balloon 
occlusion catheter 
14 
 
 
Figure 4 A.  Layout of the access ports for the Outflow and Inflow components of 
the Duo-Flo catheter 
. 
 
Figure 5 Final setup 
15 
 
 
 
 
 
 
 
 
 
 
2.2.3 Selective Cooling 
With the skin incision closed, the pig is then turned supine for the duration of the case. 
Under continuous fluoroscopy, one of the 6F sheaths is exchanged over a J wire for a 12F 
Coons dilator, followed by the 14F OFL catheter with its dilator.  The OFL is positioned 
in the thoracic portion of the descending aorta, the dilator and J-wire are removed, and 
double flushing performed.  The Activated Clotting Time (ACT) is doubled by 
intravenous heparin bolus and maintained at least two times normal for the remainder of 
the experiment.  A 5F diagnostic H1H catheter is introduced over an exchange-length 
0.038 Terumo Glidewire through the OFL and navigated into the right common carotid 
artery.  The H1H diagnostic catheter is exchanged for the IFL.  Once positioning is 
satisfactory, the OFL outflow port and IFL inflow port are attached to the extracorporeal 
circuit.  Extracorporeal circulation is established with a starting temperature of 25°C (Fig 
5).  The balloon is then inflated under fluoroscopy until occlusion (Fig 6).  Pressure 
monitoring from the distal end of the IFL and inflow rates at the extracorporeal circuit are 
checked to ensure that excessive pressures or flow rates are avoided, and that 
hemodynamic parameters are stable.  Inflow temperature is decreased in increments of 
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5°C to rapidly achieve moderate hypothermia while maintaining hemodynamic stability. 
The perfusion is terminated once 3 hours of reperfusion has occurred.   
Figure 6 Angiographic view of right and left balloon occlusion catheter with distal 
contrast stasis during inflation.   
2.2.3.1 Temperature Measurements 
The core temperature is measured by both rectal and esophageal thermometers.  For the 
most part, rectal temperatures were felt to represent the most accurate core temperature, 
but in some cases (e.g. Pig #0008) only esophageal temperatures were available. For 
brain and head temperatures, in an initial case brain and nasal temperatures followed the 
same trend and were within 2 degrees of the other (Pig #0003, unusable due to cerebral 
contusion).  Thereafter, only nasal temperatures were used because of concern of 
additional brain trauma and/or bleeding from brain probe insertion during the full 
anticoagulation required for the endovascular procedure.  This is consistent with at least 
one other selective hypothermia study in the literature (Mori).  A cutoff temperature of 
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30C was chosen.  This is significantly below what can be routinely tolerated by humans 
during whole body cooling (usually 32-34C) prior to cardiac arrhythmia onset. 
2.2.3.2 Euthanasia and brain fixation 
At the conclusion of the experiment, in situ fixation of the brain is achieved using the IFL 
balloon catheter. The animal is euthanized with 54 mg/kg Euthanyl Forte (Bimeda-MTC, 
Cambridge, ON).  The balloon is inflated, occlusion is confirmed by contrast stasis, and 
then 500 mL saline, followed by 500 mL 10% neutral buffered formalin (EMD, 
Baltimore, MD) is infused through the distal port.  The catheter is then navigated into the 
contralateral common carotid artery where the procedure is repeated. 
2.2.4 Analysis 
The brain is then removed for imaging and histology.  The postmortem animal is turned 
prone and an H-type incision is made in the scalp, centered on the midline.  A 
craniectomy is performed by connecting multiple burr holes with Leksell and Kerrison 
rongeurs, extending to the vertical walls of the cranial vault.  The dura is opened on both 
sides of the sagittal sinus and reflected back, with the sagittal sinus and falx being divided 
and reflected.  The brain is elevated anteriorly and attachments are divided, working 
posteriorly.  These include the olfactory nerve, the optic and oculomotor nerve, the 
pituitary stalk, and the brainstem.  The brain is lifted out of the cranial vault and placed in 
a plastic sling with slits in a plastic container filled with 4% Formalin.   
 
2.2.4.1 Neuroradiology  
MRI is performed postmortem, and therefore DWI sequences are not possible. T2 
volumetric sequences and T1 axial slices are examined by a neuroradiologist blinded to 
the intervention (Fig. 7).  The area of T2 signal abnormality on each slice is calculated 
using OsirixTM, and then all contiguous slices with T2 signal abnormality are summated 
to give a volume.  An identical method of calculating hemispheric volume, excluding the 
midbrain, is performed, and the ratio of T2 signal abnormality to hemisphere volume is 
calculated to give a percentage of stroke in the hemisphere.   
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Figure 7.T1 (Left) and T2 (Right) axial MRI images showing ischemic change on the 
side with the Vitamin E pellet.   
 
 
2.2.4.2 Neuropathology  
The fixed cerebrum is sliced into 1cm thick slices, placed in cassettes, and paraffin wax is 
applied.  Pathological examination is conducted by a blinded neuropathologist.  Blocks of 
coronal slices of the cerebrum were stained with hematoxylin and eosin.  This stain was 
chosen for availability and consistency with histologic studies done in selective 
hypothermia animal models (Mori).  The slices were scanned under light microscopy for 
evidence of ischemic injury. A definite change was defined as the presence of both dark 
neuronal change and perineuronal vacuolation. In order to maintain consistency, if only 
one of the aforementioned changes were present without the other, then this was not 
regarded as definite ischemic change. Two-dimensional measurements of the affected 
regions were taken manually and the areas were calculated from those measurements. 
Volumes of affected region were calculated using the area multiplied by the thickness of 
the block that showed the defined ischemic change (each block was 1.0 cm thick). 
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Figure 8  Histopathology  A.  Normal Swine Neocortex  B.  Ischemic Swine 
Neocortex 
2.2.4.3 Statistics 
Data were analyzed by an independent biostatistician (Mr L. Stitt, MSc, Statistical 
Services; lwstitt.com). Calculations included means, ranges, standard deviations, and 
standard error of the mean.  MRI results were analyzed and compared between 13 
controls and 12 selective hypothermia cases.  Pathological results were compared 
between 11 controls and 10 hypothermia cases. Student’s t-test was used for comparison 
of means. Variances were not equal; therefore a square root transformation was used to 
improve equality of variances.  Non-parametric Wilcoxon 2-sample test was also 
performed. 
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2.3 Results 
2.3.1 Animals available for analysis 
Twenty-eight pigs were utilized.  One death (#0025) occurred due to arrhythmia 
approximately 1 hour into clip occlusion time.  Autopsy demonstrated a preexisting 
pulmonic stenosis and hypertrophic cardiomyopathy. Two pigs (#0003 and #0011) were 
deemed unusable because of brain contusions and subsequent edema during exposure. 
Femoral cutdown was required in 1 case (#0021).  Advancement of the 14F OFL into the 
very small femoral artery resulted in aortic dissection.  Ultimately, the true lumen was 
entered and cooling successfully applied cooling for a limited time of 36 minutes.   The 
neuroradiology data is completely analyzed at this time. Histopathology data with 
statistics is presented for 11 animals in the normothermic group (control), and 10 animals 
in the hypothermic (neuroprotection) group. 
2.3.2 Selective cooling in this model 
Temperature trends during selective hypothermia are demonstrated in Fig 8 and 9, and in 
Table 1.  Figure 8 is a typical set of temperature curves generated during selective 
hypothermia.  Core temperature is rectal (or esophageal temperature in #0008).  The right 
and left temperatures are nasal temperatures.  Nasal temperatures follow the brain 
temperature closely, as also observed by others (Mori 2). During hypothermia, the mean 
ipsilateral (right) temperature dropped from 38°C to 26°C, with contralateral (left ) 
temperature dropping to 31.6°C.  Core temperature did drop during the experiment, but 
never below mild hypothermia levels (32-34°C).   
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Figure 9  A typical temperature profile during hypothermia
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Figure 10.Changes in rectal temperature (temp core), right nasal (temp R) and left nasal 
(temp L) with hypothermia  
 
 
 
 
 
 
 
 
 
 
 
 3 hours  6 hours  
Temperature Mean +/- 
SEM 
Mean +/- 
SEM 
Mean 
Change 
Core 38.0+/-0.2  34.0+/-
0.4  
4.0  
Right 38.0+/-0.2  26.5+/-
0.8  
11.5  
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2.3.3 Metrics related to the model 
The design of the experiment attempted to replicate the realities in establishing vascular 
access and extracorporeal circulation once three hours of ischemia had already taken 
place.  The time needed to set up the system and begin cooling, the overall length of 
cooling time achieved during the second 3 hour window, and the time to achieve 
moderate hypothermia are shown in Table 2.  We also looked at the lowest temperature 
recorded ipsilaterally (the temperature nadir).  The decision as to the depth of 
hypothermia was made on clinical grounds, based on the animal’s tolerance during the 
experiment.  The average length of time to establish the extracorporeal circulation or 
bypass was over 1 hour but highly variable.  Once extracorporeal circulation was 
established, moderate hypothermia (less than 30C) could be achieved in less than 30 
minutes.  Thus the total time from reperfusion to moderate hypothermia was just below 
an hour and a half, so falling within the 3-4.5 hour window following ischemic insult.  
Left 37.8+/-0.3  31.6+/-
1.0 
6.1 
Table 1  Changes in mean temperature in the hypothermia cohort 
24 
 
The lowest temperature achieved was often quite lower than what was sustained for the 
duration of cooling.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.4 Hemodynamic parameters during hypothermia 
We evaluated several hemodynamic parameters during the study, with particular attention 
to possible instability from the hypothermia protocol.  Several hemodynamic parameters, 
(core temperature, heart rate, mean arterial blood pressure) and several arterial blood gas 
 Mean  Range 
Set up Time (min) 60.3+/-10.3  22-144 
Temp Nadir (oC) 24.4+/-0.5  21.8-27.5 
Time to <30oC (min) 25.4+/-5.4  6-65 
Total Cooling (min) 109.6 +/- 9.8 36-150 
Total Time to <30oC 
(min) 
85.7+/-10.5  47-155 
Table 2  Hypothermia therapeutic parameters (mean +/- SEM) 
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data points (oxygen, hemoglobin, glucose, and pH) were evaluated for changes in the 
hypothermia group versus controls over the course of the experiment.   Using analysis of 
covariance, a significant drop was seen only in core temperature (p<0.001) and in pH 
(p<0.001) between controls and hypothermia during the last 3 hours of the experiment.  
2.3.5 Selective hypothermia and stroke volume 
Stroke volumes determined by MRI are presented below.  In Table 3 and Figure 10, the 
data for the means and standard error of the mean for each group (n=13 control, 12 
hypothermia)  is presented.   The hypothermia group mean (stroke as % of hemisphere 
volume) is smaller than control, with a wide variance.  This reached statistical 
significance using unpaired Student’s t test (p< 0.05).  
 Control Hypothermia P Value 
Mean+/-SEM 0.050+/-0.016 0.009+/-0.005 0.042 
Median 0.050 0.000  
Table 3  MRI-derived stroke % of hemispheric volume 
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Figure 11 Ratio of stroke volume to hemisphere volume on MRI 
Stroke volumes determined by pathology are seen in fig 12 and Table 4.  Mean 
hypothermia total stroke volumes were 61.6% of controls.  Mean hypothermia largest 
stroke volumes were 55.8% of controls.  However, in both cases the mean stroke volume 
difference is not statistically significant, due to the wide variance.  We looked for any 
correlation between duration of cooling and the stroke volume, using two cooling time 
measures.  The first is the total time the perfusion pump was active (actual cooling time).  
The second is the sum of setup time and time to achieve moderate hypothermia.  All r 
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values were less than 0.25, suggesting no correlation.
 
Figure 12. Graphical illustration of mean pathology volumes (expressed as mean +/- 
standard error) 
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 Control 
(n=11) 
Hypothermia 
(n=10) 
P Value 
Total Path 
Volume (cm3) 
1.12+/-0.31 0.69+/-0.25 0.292 
Largest Path 
Volume (cm3) 
0.95+/-0.32 0.53+/-0.19 0.278 
Table 4 Pathology-derived stroke volume 
 
2.4 Discussion 
2.4.1 Feasibility of rapid-onset moderate hypothermia 
This study confirms other work in animals and humans that femoral-to-carotid bypass can 
rapidly induce hypothermia which is selective to the cranium and particularly to brain 
tissue.  Our mean time to moderate hypothermia (<30C) once the pump was turned on 
was 25.4 min +/- 5min, and mean final temperature of 26.5°C.  Verdura et al were able to 
cool the brain to 15°C on average by 35 min (dogs), Schwartz achieved 18.5°C in an 
average of 26 +/- 13 min, and 24.5°C in 12 +/- 6 min (baboons), and Lownie et al were 
able to drop brain temperature to 26.8°C in 12 minutes (human) (Verdura, Schwartz, 
Lownie).  In the COOLAID trial utilizing endovascular venous cooling, mean time to 
cooling was 77 +/- 44 minutes to a target of 33°C, which is relatively mild (DeGeorgia).  
In contrast, whole body surface cooling typically takes hours (deGeorgia, Froehler), and 
again is limited to 32-34°C typically.  In ICTuS-L, median time to target temperature 
(after catheter placement) was 138.3 +/- 198.9 min 
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Our experiment is the first to use a purely percutaneous approach to produce selective 
hypothermia of such a degree.  Ice cold saline has been previously reported to reduce 
temperatures selectively but reductions in a limited safety trial were very modest (Choi).  
Although cerebral metabolic rate undergoes predictable reduction with hypothermia, it is 
unknown what degree of hypothermia is necessary to provide meaningful 
neuroprotection, especially in acute stroke.  Some authors suggest that mild hypothermia 
may be as effective as moderate or deep hypothermia because of the added risk with 
colder temperatures, but in acute stroke this remains unknown (Yenari).  The selective 
hypothermia method clearly gives reproducible degrees of moderate hypothermia rapidly.  
Thus, if the degree of hypothermia or the rapidity with which it is introduced are 
significant variables in determining outcome, then selective hypothermia should produce 
superior results.  
What is clear from our data and that of other groups is that endovascular selective 
hypothermia is very efficient in attaining moderate hypothermia in the brain.  Our data 
also shows that systemic cooling does occur even with selective hypothermia, which is in 
line with Mori and Schwartz, in which hypothermic perfusion was continued for 12 
hours.   The degree of mild systemic hypothermia should be tolerable but measures of 
this such as arrhythmia frequency was not performed.  Another potential consequence of 
systemic hypothermia, coagulopathy, would be difficult to evaluate as the catheterized 
animals were heparinized during the procedure.  The duration and degree of hypothermia 
required for potential neuroprotection is still unknown.   
Statistically significant drops were seen in core temperature (noted above) and in 
systemic pH.  Other parameters were not significantly affected.  The drop in systemic pH 
may be due to lower extremity ischemia from the catheter, although this hypothesis 
remains to be tested (Thomas Forbes, MD, personal communication).  The relative 
stability of other factors such as mean arterial blood pressure, blood oxygenation, and 
hemoglobin between normothermic and hypothermic groups suggests that the process of 
placing the endovascular device and utilizing extracorporeal perfusion-pump to induce 
selective hypothermia does not destabilize the animal.   
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2.4.2  Trend to reduction in stroke volumes 
Both by MRI and histopathology, the mean stroke volume was decreased by 
hypothermia.  The decrease in mean stroke volume measured by histology was not 
statistically significant compared with controls but was statistically significant for the 
MRI measurements.  There is a wide range of stroke volumes in both control and 
hypothermia animals.   There are a number of variables that could account for this, but 
interestingly, it mirrors the experience of the COOLAID study (DeGeorgia).  In 
COOLAID, hypothermia could be rapidly induced in humans, but a statistically 
significant reduction in stroke volume (measured as % increase from onset to day 3-5) 
was not seen.   Again, their numbers show a difference in mean between controls (108+/-
142.4%, n=11)) and well-cooled hypothermia patients (72.9+/-95.2%, n=8) but there was 
a large variance.  However, in the second Schwartz baboon study, a significant reduction 
in stroke volumes was seen using FLAIR sequence on MRI.  The number of animals in 
each group was very small (4 each) (Schwartz 2).  In animal studies, time to hypothermia 
is controlled, while in the human COOLAID and ICTuS-L trials, up to 8 hours could pass 
before even mild hypothermia was achieved, which could diminish or even eliminate any 
clinical benefit. 
 
2.4.3 Limitations of the study 
This study has several limitations.  First the choice of experimental animal, while helpful 
from an endovascular experience standpoint, has limitations under anesthesia.  The 
experiment is long (usually about 8h under anesthesia), and pigs can have cardiac issues 
that develop under anesthesia.  By the end of the experiment, the animals are almost 
universally on medical blood pressure support. This may have contributed to some of the 
variability in time to cooling, as several experiments required transiently stopping the 
cooling process during stabilization of the animal.  By experimental design, this occurred 
late in the course, when the animal had already been under anesthesia for many hours.   
Second, we chose to selectively clip only one MCA branch.  This makes for a smaller and 
more focal stroke, but also raises the possibility that intracranial collateral flow reduced 
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the area of significant damage, contributing to the wide variability of stroke volumes.  
However, this is not unlike the human acute stroke scenario.  Furthermore, we did not 
confirm that removing the clip actually allowed reperfusion of the ischemic territory.  We 
were able to see blanching at the distal to the clip application site, and then return of flow 
at the occlusion point following removal of the temporary clip, which suggested return of 
flow in the vessel, but did not elucidate the degree of reperfusion in the affected territory.  
Confirmation of patent vessels following temporary occlusion by angiography has been 
reported (Sakoh).  NIRS technology has the potential to noninvasively track cerebral 
blood flow in the hemisphere (Cooper).   Another alternative would be indocyanine green 
fluorescence angiography, which is used clinically to evaluate blood vessel patency, but 
requires a special filter on the microscope.  Another option would be motor evoked 
potentials (Schwartz). 
A third issue relates to our choice of sequences on MRI.  Diffusion weighted imaging is 
the gold standard for determining a volume of stroke, but requires a living creature.  
Since MRI was obtained postmortem in this study, DWI was not applicable.  Thus we 
used T1 and T2, but DWI is considered more sensitive (Knight).  A future experiment 
might include placing a living animal during or just after cooling to assess the stroke 
volume. 
Finally, since the occlusion ended at 3 hours, reperfusion began at that time.  The 
experimental results may reflect changes in reperfusion-related damage, rather than 
stroke damage.  We measured stroke volumes accurately, but microscopic effects 
(changes in local chemical substrates) and macroscopic effects (edema or raised 
intracranial pressure) due to reperfusion were not evaluated.  Thus potential beneficial 
effects of hypothermia on reperfusion injury might have been missed in this model.   
 
2.4.4 Strengths of the study. 
There are three major strengths to this study.  First, the imaging and pathology review 
was conducted by qualified personnel who were completely blinded to the intervention.   
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These specialists are trained to evaluate stroke in humans, but assuming that stroke 
should follow similar patterns in pigs, they should be able to provide an unbiased 
evaluation of stroke volumes.  We acknowledge the difficulty in transferring pattern 
recognition from one species to another, and this may reduce the overall sensitivity of 
analysis.  Nevertheless, we feel that the blinded nature of the analysis allows for the 
highest chance of unbiased assessment of selective hypothermia in acute stroke.   
Second, the design of the study evaluated intervention well after the ischemic insult.  The 
three-hour lag time prior to intervention is consistent with typical presentation time 
frames in human acute ischemic stroke.  While it is known that even delayed 
hypothermia can reduce stroke volumes, the effect is reduced with delay in treatment and 
animal studies have only examined the period of 1.5 to 2 hours post ischemia. (Xue, Ji).  
If hypothermia is to act as a bridge to recanalization, it has to be effective in the time 
frames of recanalization, which for IV tPA are up to 4.5 hours, and for mechanical 
thrombectomy may be up to 6 hours.  Our study suggests that in the 3-6 hour time frame, 
adding hypothermia to recanalization can reduce stroke volume but the number needed to 
show significance may be quite large.   
Finally, this represents the largest paired study of selective hypothermia in a large animal 
model.  Table 5 shows comparable series comparing normothermia with hypothermia.  
Our study is unique in its purely endovascular approach to selective cooling, and thus 
presents the potential advantages of rapid induction as well as selectivity, through the use 
of novel interventional stroke technology.    
Table 5  Comparison Animal Series 
Author Method Total N Normothermia Hypothermia 
Ohta Bypass   12 
Imai None 16 5 MCAO  
Sakoh None 15 5  
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Schwartz Bypass 12  12 
Schwartz Bypass 8 4 4 
Mori Bypass 12 6 6 
Zhang Epidural 12 4 6 
Verdura Bypass 21 5 16 
Mattingly Bypass 25 13 12 
 
2.4.5 Future directions 
This study raises intriguing questions regarding the efficacy of hypothermia in the face of 
acute stroke.  By its design, we have made assumptions regarding both the development 
of focal cerebral ischemia in this model and its response to hypothermia.  We elected to 
clip only one MCA branch. It would be useful to assess the effect of clipping all MCA 
branches, in terms of stroke volume and variability.  The timing of clip removal, 
including whether to remove it at all, is another area worthy of exploration.  Hypothermia 
could be effective in reducing stroke volumes even with no recanalization.  Furthermore, 
the hypothermia group was subjected to a significant change in placing the catheter, 
including repositioning the animal on its back for the exchange of sheath and perfusion. 
Potentially one could make the two groups more equivalent by performing the same 
catheter exchange on the controls without perfusion, or perfuse controls with 
normothermic blood.  This would make any observed differences in outcome more 
directly related to cooling.  Finally, it would be interesting to track the effect of 
hypothermia on stroke volume using real-time MRI.  This would require placing the 
experimental animal in the MRI at least at the end, if not during, cooling.  Logistical 
hurdles to this are substantial, as the entire operation, including life support and catheter 
would need to be MRI compatible at least at some point, and transferring an animal to 
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MRI while on inotropic support might destabilize it, causing a premature end to the 
experiment.    
2.5 Conclusion 
This experimental protocol demonstrated the feasibility of a focal cerebral ischemia 
model in 50kg swine via a transcranial approach, without the need for enucleation of the 
eye.  We also developed a unique method of in situ perfusion fixation for the brain 
without the need for thoracotomy.  We demonstrated that moderate selective hypothermia 
is rapidly achievable through a completely percutaneous endovascular approach and our 
times and temperatures correspond well with the results of other animal studies of 
selective hypothermia using varying forms of femoral-to-carotid bypass. Using moderate 
selective hypothermia, there is a trend toward reduced stroke volume on histopathology, 
and a statistically significant reduction in stroke volume on MRI, within the 3-6 hour 
postischemic timeframe.   These results are promising, and further study is warranted.   
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